Thomsen disease
| Thomsen disease | |
| ICD-10 | G71.1 |
|---|---|
| ICD-9 | 359.2 |
| OMIM | 160800 |
| DiseasesDB | 8736 |
| MeSH | D009224 |
|
WikiDoc Resources for Thomsen disease |
|
Articles |
|---|
|
Most recent articles on Thomsen disease Most cited articles on Thomsen disease |
|
Media |
|
Powerpoint slides on Thomsen disease |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Thomsen disease at Clinical Trials.gov Trial results on Thomsen disease Clinical Trials on Thomsen disease at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Thomsen disease NICE Guidance on Thomsen disease
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Thomsen disease Discussion groups on Thomsen disease Patient Handouts on Thomsen disease Directions to Hospitals Treating Thomsen disease Risk calculators and risk factors for Thomsen disease
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Thomsen disease |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Thomsen disease, a form of Myotonia congenita, is a muscular genetic disorder characterized by muscle stiffness (cramp) and an inability of the muscle to relax after a voluntary contraction. The affected muscle functions normally after a few repetitions.
Causes
It is associated with mutations in the chloride channel gene CLCN1.
Presentation
The disorder only affects voluntary muscles, so involuntary muscles such as the heart or muscles involved in the digestion process are not affected.
Treatment and prognosis
There is no known cure but some drugs may relieve symptoms. These include: Dilantin, Procainamide, Phenytoin and Mexiletine.
The disease is not fatal.
History
Julius Thomsen, a Danish physician, was the first to describe the disease, citing symptoms of his own family members.